Xencor's Total Assets for the quarter that ended in Mar. 2024 was $884.3 Mil.
During the past 12 months, Xencor's average Total Assets Growth Rate was 61.70% per year.
During the past 3 years, the average Total Assets Growth Rate was 53.00% per year.
During the past 5 years, the average Total Assets Growth Rate was 12.80% per year.
During the past 10 years, the average Total Assets Growth Rate was 33.50% per year.
During the past 13 years, Xencor's highest 3-Year average Total Assets Growth Rate was 217.30%. The lowest was -22.20%. And the median was 29.00%.
Total Assets is connected with ROA %. Xencor's annualizedROA % for the quarter that ended in Mar. 2024 was -29.63%. Total Assets is also linked to Revenue through Asset Turnover. Xencor's Asset Turnover for the quarter that ended in Mar. 2024 was 0.01.
Xencor Total Assets Historical Data
The historical data trend for Xencor's Total Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.
Xencor's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note:
The Net Income data used here is four times the quarterly (Mar. 2024) data.
In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.
Total Assets is linked to total revenue through Asset Turnover.
Xencor's Asset Turnover for the quarter that ended in Mar. 2024 is
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.
Xencor Total Assets Related Terms
Thank you for viewing the detailed overview of Xencor's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.
Xencor Inc is a clinical-stage biopharmaceutical company based in the United States. It focuses on discovering and developing engineered monoclonal antibody and other protein therapeutics to treat severe and life-threatening diseases with unmet medical needs. The company uses its XmAb technology platform to create antibody product candidates such as XmAb5871 and XmAb7195. It also has a few pre-clinical stage candidates in its portfolio such as XmAb14045 and XmAb13676. It earns its revenue from research and development collaborations and licenses of its internally developed drug candidates.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XNCR has been successfully added to your 